Culver K - Search Results

1

Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology network.

Pokras S, Tseng WY, Espirito JL, Beeks A, Culver K, Nadler E. Pokras S, et al. Among authors: culver k. Future Oncol. 2022 Oct;18(32):3637-3650. doi: 10.2217/fon-2022-0477. Epub 2022 Aug 26. Future Oncol. 2022. PMID: 36018238 Free article.

2

Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma.

Eliason L, Grant L, Francis A, Cardellino A, Culver K, Chawla SP, Arbuckle R, Pokras S. Eliason L, et al. Among authors: culver k. J Patient Rep Outcomes. 2022 May 4;6(1):43. doi: 10.1186/s41687-022-00450-1. J Patient Rep Outcomes. 2022. PMID: 35507231 Free PMC article.

3

Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices.

Jonasch E, Signorovitch JE, Lin PL, Liu Z, Culver K, Pal SK, Scott JA, Vogelzang NJ. Jonasch E, et al. Among authors: culver k. Curr Med Res Opin. 2014 Oct;30(10):2041-50. doi: 10.1185/03007995.2014.938730. Epub 2014 Jul 9. Curr Med Res Opin. 2014. PMID: 24983741

4

Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.

Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE. Horn L, et al. Among authors: culver k. Lung Cancer. 2019 Feb;128:74-90. doi: 10.1016/j.lungcan.2018.12.003. Epub 2018 Dec 6. Lung Cancer. 2019. PMID: 30642457

5

Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United States.

Signorovitch JE, Vogelzang NJ, Pal SK, Lin PL, George DJ, Wong MK, Liu Z, Wang X, Culver K, Scott JA, Jonasch E. Signorovitch JE, et al. Among authors: culver k. Curr Med Res Opin. 2014 Nov;30(11):2343-53. doi: 10.1185/03007995.2014.949645. Epub 2014 Aug 27. Curr Med Res Opin. 2014. PMID: 25105304

6

Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States.

Wong MK, Jonasch E, Pal SK, Signorovitch JE, Lin PL, Wang X, Liu Z, Culver K, Scott JA, George DJ, Vogelzang NJ. Wong MK, et al. Among authors: culver k. Expert Opin Pharmacother. 2015 Apr;16(6):805-19. doi: 10.1517/14656566.2015.1020298. Epub 2015 Mar 12. Expert Opin Pharmacother. 2015. PMID: 25766864

7

Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US.

Perrin A, Sherman S, Pal S, Chua A, Gorritz M, Liu Z, Wang X, Culver K, Casciano R, Garrison LP. Perrin A, et al. Among authors: culver k. J Med Econ. 2015 Mar;18(3):200-9. doi: 10.3111/13696998.2014.985789. Epub 2014 Nov 26. J Med Econ. 2015. PMID: 25422989 Free article.

8

Treatment, overall survival, and costs in patients with ALK-positive non-small-cell lung cancer after crizotinib monotherapy.

Guérin A, Sasane M, Wakelee H, Zhang J, Culver K, Dea K, Nitulescu R, Galebach P, Macalalad AR. Guérin A, et al. Among authors: culver k. Curr Med Res Opin. 2015 Aug;31(8):1587-97. doi: 10.1185/03007995.2015.1057115. Epub 2015 Jun 29. Curr Med Res Opin. 2015. PMID: 26029864

9

Treatment Patterns and Early Outcomes of ALK-Positive Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study.

Bendaly E, Dalal AA, Culver K, Galebach P, Bocharova I, Foster R, Sasane M, Macalalad AR, Guérin A. Bendaly E, et al. Among authors: culver k. Adv Ther. 2017 May;34(5):1145-1156. doi: 10.1007/s12325-017-0527-6. Epub 2017 Apr 12. Adv Ther. 2017. PMID: 28405961

10

Economic analysis of BRAF gene mutation testing in real world practice using claims data: costs of single gene versus panel tests in patients with lung cancer.

Dalal AA, Guerin A, Mutebi A, Culver KW. Dalal AA, et al. J Med Econ. 2018 Jul;21(7):649-655. doi: 10.1080/13696998.2018.1450261. Epub 2018 Mar 26. J Med Econ. 2018. PMID: 29516752 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters